🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Na Zhao

Zhejiang Chinese Medical University

ORCID: 0000-0002-8161-3380

Also affiliated with Guangxi Medical University, Chongqing University of Science and Technology, Zunyi Medical University, Yunnan University, Fudan University, Wenzhou Medical University, Northwest University, Wenzhou Hospital of Traditional Chinese Medicine, Shanghai Stomatological Hospital, First Affiliated Hospital of Xi'an Jiaotong University, First Hospital of Xi'an, Chongqing University of Technology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer”.

CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer

JCI Insight(2024)10.1172/jci.insight.182621

N/A

0.471DataRank · unranked

15 citations

Xiaoxin Hao, Hilda L. Chan, Na Zhao, Diego A. Pedroza, Fengshuo Liu +9 more

Noncanonical Wnt/Ror2 signaling regulates cell-matrix crosstalk to prompt directional tumor cell invasion and dissemination in breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.15.444295

N/A

0DataRank · unranked

1 citations

Na Zhao, Andrea Pedroza, Jeffrey M. Rosen, Chad J. Creighton, Kevin Roarty +1 more

Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

Journal of Clinical Investigation(2023)10.1172/jci172503

N/A

0DataRank · unranked

30 citations

Elena B. Kabotyanski, Alexander B. Saltzman, Anna Malovannaya, Xueying Yuan, Lucas C. Reineke +16 more

Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition

Nature Communications(2021)10.1038/s41467-021-24545-3

N/A

0DataRank · unranked

60 citations

Reid T. Powell, Xueying Yuan, Goeun Bae, Kevin Roarty, Fabio Stossi +8 more

Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.30.651522

N/A

0DataRank · unranked

1 citations

Xueying Yuan, Fengshuo Liu, Hilda L. Chan, Christina Zhang, William Bowie +15 more

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

UNC Libraries(2025)10.17615/se9n-4867

N/A

0DataRank · unranked

0 citations

Cheng Fan, Elena B. Kabotyanski, Alexander B. Saltzman, Kazem Safari, Diego A. Pedroza +16 more

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.28.559973

N/A

0DataRank · unranked

3 citations

Elena B. Kabotyanski, Alexander B. Saltzman, Anna Malovannaya, Xueying Yuan, Lucas C. Reineke +16 more